Management of Massive Pleural Effusion

Primary Strategy: Chemical Pleurodesis

The American Thoracic Society recommends chemical pleurodesis using sterile talc (2-5g) as the most effective approach to decrease pleural fluid production in massive pleural effusion, achieving approximately 90% success rates in preventing fluid reaccumulation 1, 2, 3
Talc pleurodesis is the gold standard for preventing recurrent pleural fluid production, with the highest success rate among available sclerosing agents 1, 2, 3
Sterile talc achieves 90% success rates compared to tetracycline (65%), doxycycline (76%), or bleomycin 1, 2, 3

The British Thoracic Society recommends large pleural effusions to be drained in a controlled fashion to prevent re-expansion pulmonary edema while preparing for pleurodesis 1, 2, 3, 4
Avoid evacuating more than 1-1.5 L at one time to prevent re-expansion pulmonary edema 1, 2, 3, 4
Stop immediately if patient develops chest discomfort, persistent cough, or vasovagal symptoms 1, 2, 3, 4, 5

Even with partial pleural apposition, chemical pleurodesis should still be attempted and may provide symptomatic relief 1, 2, 3
Incomplete re-expansion may result from trapped lung (visceral peel), pleural loculations, proximal airway obstruction, or persistent air leak 1, 2, 3

The European Respiratory Society recommends intrapleural fibrinolytic therapy using urokinase (100,000 IU daily for 3 days) or streptokinase (250,000 IU twice daily for three doses) to improve drainage in loculated effusions 6, 7
Results in greater than two-thirds reduction in effusion size in 72% of patients 6, 7

Based on efficacy, safety, and cost considerations, sterile talc (2-5g) is recommended with a 90% success rate and lowest cost 1, 2, 3
Administer lignocaine 3 mg/kg (maximum 250 mg) intrapleurally immediately before sclerosant to reduce pain 1, 2, 3, 4

Re-expansion pulmonary edema is a rare but serious complication that results from rapid expansion of collapsed lung, and can be prevented by strict adherence to volume limitations and drainage rates 1, 2, 3, 4
Do not withhold pleurodesis attempt even if complete lung re-expansion cannot be achieved, as partial pleurodesis still provides symptomatic benefit in most patients 1, 2, 3

Malignancy is the most common cause of massive pleural effusion, and absence of contralateral mediastinal shift suggests mediastinal fixation, mainstem bronchus obstruction, or extensive pleural involvement 8